title: Intermittent Short Course Rifapentine-Isoniazid Combination for Preventing Tuberculosis in Children: Evidence based Medicine Viewpoint.
authors.affiliation: Department of Pediatrics, PGIMER, Chandigarh, India. dr.joseph.l.mathew@gmail.com.
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Mathew
authors.forename: T Jacob
authors.initials: TJ
authors.lastname: John
authors.forename: Ankit
authors.initials: A
authors.lastname: Parakh
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D055985:Latent Tuberculosis / Q000517:prevention & control*; D008297:Male; D012293:Rifampin / Q000031:analogs & derivatives*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin